The EchoHeart Transvaginal Doppler Probe underwent extensive clinical trials and field studies to ascertain its safety and efficacy for fetal heart detection. The studies also showed that EchoHeart probe allowed care providers and patients to hear their baby's earliest heartbeats with a 71% success rate at 6 - 8 weeks gestation, and with continued use that success rate increased even more. All participating clinicians were impressed and enthusiastic about the EchoHeart Probe's ease of use and sensitivity and the patients were thrilled to hear their baby's heartbeat earlier.
- FDA Cleared
- 5MHz Continuous-wave Doppler
- Exchangeable and Versatile Probes
- Slim Design for Patient Comfort
- Best used for earlier FHT detection with patients who are obese or have a retroverted uterus
| |
|
